Daniel J Dorman Net Worth & Insider Trades

Daniel J Dorman - Director, Pipex Pharmaceuticals, Inc

As of November 13, 2007

What is Daniel J Dorman's Net Worth?

The current estimated net worth of Pipex Pharmaceuticals, Inc's Director, Daniel J Dorman, is estimated to be about $16.4M . Daniel J Dorman owns about 742,626 units of Pipex Pharmaceuticals, Inc common stock. Recently at Pipex Pharmaceuticals, Inc, Daniel J Dorman has sold an estimated value of $0 worth.

What is Daniel J Dorman's Past Insider Trading?

Daniel J Dorman's largest purchase order was 253,731 units , worth over $563.28K on November 13, 2007. In total, Daniel J Dorman has made about 2 transactions recently at Pipex Pharmaceuticals, Inc. Daniel J Dorman usually trades in November, with the busiest year in 2007.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Daniel J Dorman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Pipex Pharmaceuticals, Inc's Past Insider Trades?

Pipex Pharmaceuticals, Inc's most recent insider trade came on April 15, 2008 by Steve H Kanzer who bought 7,136,380 units worth $44.43K . In the last year, insiders at Pipex Pharmaceuticals, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in November and July, with the busiest year in 2007. The most active traders at the company are Steve H Kanzer, Chief Executive Officer,  Daniel J Dorman, Director,  and Bud Holman As Attorney-In-Fact .

PIPEX PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...